Basiliximab: A Viewpoint by Björn Nashan

ISSN： 0012-6667

Source： Drugs, Vol.57, Iss.2, 1999-02, pp. : 214-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Memantine: A Viewpoint by Hans Förstl

By Förstl H.

Drugs & Aging, Vol. 20, Iss. 6, 2003-01 ,pp. : 477-478

Adis International

Access to resources Recommend Favorite

Bendamustime: A Viewpoint by Patrick Schöffski and Arnold Ganser

By Schöffski P. Ganser A.

Drugs, Vol. 61, Iss. 5, 2001-01 ,pp. : 639-640

Adis International

Access to resources Recommend Favorite

Basiliximab

By Onrust S.V. Wiseman L.R.

Drugs, Vol. 57, Iss. 2, 1999-02 ,pp. : 207-213

Adis International

Access to resources Recommend Favorite

Brimonidine/Timolol: A Viewpoint by Francisco J. Goñi

By Goñi Francisco J.

Drugs & Aging, Vol. 23, Iss. 9, 2006-01 ,pp. : 762-763

Adis International

Access to resources Recommend Favorite

Exemestane: A Viewpoint by Per E. Lønning

By Lønning P.E.

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 681-682

Adis International

Access to resources Recommend Favorite